Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer
Effective antiretroviral therapy (ART) is now nearly ubiquitous. However, the survival benefits conferred with ART contribute to an aging human immunodeficiency virus (HIV) population and increased risk of chronic diseases, like atherosclerotic cardiovascular disease (ASCVD). Furthermore, HIV is a k...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | American Journal of Preventive Cardiology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667724002563 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846128199312867328 |
|---|---|
| author | Elizabeth A. Kobe Aarti Thakkar Sarina Matai Esra Akkaya Neha J. Pagidipati Robert W. McGarrah Gerald S. Bloomfield Nishant P. Shah |
| author_facet | Elizabeth A. Kobe Aarti Thakkar Sarina Matai Esra Akkaya Neha J. Pagidipati Robert W. McGarrah Gerald S. Bloomfield Nishant P. Shah |
| author_sort | Elizabeth A. Kobe |
| collection | DOAJ |
| description | Effective antiretroviral therapy (ART) is now nearly ubiquitous. However, the survival benefits conferred with ART contribute to an aging human immunodeficiency virus (HIV) population and increased risk of chronic diseases, like atherosclerotic cardiovascular disease (ASCVD). Furthermore, HIV is a known risk enhancer of ASCVD and acknowledged as such in the current 2018 AHA/ACC Blood Cholesterol guidelines [1]. This makes cardiovascular risk factor identification and modification among people living with HIV (PLWH) of increasing importance to prevent cardiovascular events. In this review, we aim to summarize the epidemiology and pathogenesis of how HIV is linked to atherogenesis and to discuss cardiometabolic risk factor modification specific to PLWH, covering obesity, hypertension, insulin resistance, metabolic dysfunction-associated steatotic liver disease, and dyslipidemia. |
| format | Article |
| id | doaj-art-abd1b9361a1a4324bfd0ab263ef5ebed |
| institution | Kabale University |
| issn | 2666-6677 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | American Journal of Preventive Cardiology |
| spelling | doaj-art-abd1b9361a1a4324bfd0ab263ef5ebed2024-12-11T05:57:45ZengElsevierAmerican Journal of Preventive Cardiology2666-66772024-12-0120100888Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancerElizabeth A. Kobe0Aarti Thakkar1Sarina Matai2Esra Akkaya3Neha J. Pagidipati4Robert W. McGarrah5Gerald S. Bloomfield6Nishant P. Shah7Duke University Hospitals, 2301 Erwin Road, Suite 7400, Cubicle 13, Durham, NC 27710, USA; Corresponding author.Duke University Hospitals, 2301 Erwin Road, Suite 7400, Cubicle 13, Durham, NC 27710, USARaleigh Charter High School, 1307 Glenwood Ave, Raleigh, NC 27605, USADuke University School of Medicine, 8 Searle Center Dr, Durham, NC 27710, USA; Duke Molecular Physiology Institute, 300 N Duke St, Durham, NC 27701, USADuke University Hospitals, 2301 Erwin Road, Suite 7400, Cubicle 13, Durham, NC 27710, USA; Duke University School of Medicine, 8 Searle Center Dr, Durham, NC 27710, USA; Duke Clinical Research Institute, 300 W Morgan St, Durham, NC 27701, USADuke University Hospitals, 2301 Erwin Road, Suite 7400, Cubicle 13, Durham, NC 27710, USA; Duke University School of Medicine, 8 Searle Center Dr, Durham, NC 27710, USA; Duke Molecular Physiology Institute, 300 N Duke St, Durham, NC 27701, USADuke University Hospitals, 2301 Erwin Road, Suite 7400, Cubicle 13, Durham, NC 27710, USA; Duke Clinical Research Institute, 300 W Morgan St, Durham, NC 27701, USA; Duke Global Health Institute, 310 Trent Dr, Durham, NC 27710, USADuke University Hospitals, 2301 Erwin Road, Suite 7400, Cubicle 13, Durham, NC 27710, USA; Duke University School of Medicine, 8 Searle Center Dr, Durham, NC 27710, USA; Duke Clinical Research Institute, 300 W Morgan St, Durham, NC 27701, USAEffective antiretroviral therapy (ART) is now nearly ubiquitous. However, the survival benefits conferred with ART contribute to an aging human immunodeficiency virus (HIV) population and increased risk of chronic diseases, like atherosclerotic cardiovascular disease (ASCVD). Furthermore, HIV is a known risk enhancer of ASCVD and acknowledged as such in the current 2018 AHA/ACC Blood Cholesterol guidelines [1]. This makes cardiovascular risk factor identification and modification among people living with HIV (PLWH) of increasing importance to prevent cardiovascular events. In this review, we aim to summarize the epidemiology and pathogenesis of how HIV is linked to atherogenesis and to discuss cardiometabolic risk factor modification specific to PLWH, covering obesity, hypertension, insulin resistance, metabolic dysfunction-associated steatotic liver disease, and dyslipidemia.http://www.sciencedirect.com/science/article/pii/S2666667724002563Cardiometabolic diseasesHuman immunodeficiency virusAtherosclerosisPrimary preventionSecondary preventionRisk modification |
| spellingShingle | Elizabeth A. Kobe Aarti Thakkar Sarina Matai Esra Akkaya Neha J. Pagidipati Robert W. McGarrah Gerald S. Bloomfield Nishant P. Shah Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer American Journal of Preventive Cardiology Cardiometabolic diseases Human immunodeficiency virus Atherosclerosis Primary prevention Secondary prevention Risk modification |
| title | Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer |
| title_full | Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer |
| title_fullStr | Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer |
| title_full_unstemmed | Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer |
| title_short | Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer |
| title_sort | optimizing cardiometabolic risk in people living with human immunodeficiency virus a deep dive into an important risk enhancer |
| topic | Cardiometabolic diseases Human immunodeficiency virus Atherosclerosis Primary prevention Secondary prevention Risk modification |
| url | http://www.sciencedirect.com/science/article/pii/S2666667724002563 |
| work_keys_str_mv | AT elizabethakobe optimizingcardiometabolicriskinpeoplelivingwithhumanimmunodeficiencyvirusadeepdiveintoanimportantriskenhancer AT aartithakkar optimizingcardiometabolicriskinpeoplelivingwithhumanimmunodeficiencyvirusadeepdiveintoanimportantriskenhancer AT sarinamatai optimizingcardiometabolicriskinpeoplelivingwithhumanimmunodeficiencyvirusadeepdiveintoanimportantriskenhancer AT esraakkaya optimizingcardiometabolicriskinpeoplelivingwithhumanimmunodeficiencyvirusadeepdiveintoanimportantriskenhancer AT nehajpagidipati optimizingcardiometabolicriskinpeoplelivingwithhumanimmunodeficiencyvirusadeepdiveintoanimportantriskenhancer AT robertwmcgarrah optimizingcardiometabolicriskinpeoplelivingwithhumanimmunodeficiencyvirusadeepdiveintoanimportantriskenhancer AT geraldsbloomfield optimizingcardiometabolicriskinpeoplelivingwithhumanimmunodeficiencyvirusadeepdiveintoanimportantriskenhancer AT nishantpshah optimizingcardiometabolicriskinpeoplelivingwithhumanimmunodeficiencyvirusadeepdiveintoanimportantriskenhancer |